Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Cruickshank

Showing results (91-100 of 343) with videos related to

Pageof 35
Sort By:
Science (New York, N.Y.)|October 20, 1978
Gordon research conferences: winter program, 1979A M Cruickshank
Science (New York, N.Y.)|March 13, 1981
Gordon research conferencesA M Cruickshank
BMJ (Clinical Research Ed.)|October 14, 2011
Don't beta blockers still have a role in hypertension?John M Cruickshank
The American Journal of Cardiology|March 25, 1993
The xamoterol experience in the treatment of heart failureJ M Cruickshank
The New England Journal of Medicine|July 2, 1992
How far to lower blood pressureJ M Cruickshank
Cardiovascular Drugs and Therapy|August 1, 1993
Phosphodiesterase III inhibitors: long-term risks and short-term benefitsJ M Cruickshank
European Heart Journal|September 1, 1992
The role of coronary perfusion pressureJ M Cruickshank
Journal of Cardiovascular Pharmacology|January 1, 1995
The beta 1 hyperselectivity in beta-blocker treatmentJ M Cruickshank
Lancet (London, England)|June 28, 1980
Beta-blocking agentsJ M Cruickshank
Science (New York, N.Y.)|October 11, 1991
Gordon research conferencesA M Cruickshank
Pageof 35

Showing results (91-100 of 343) with videos related to

Sort By:
Pageof 35
Science (New York, N.Y.)|October 20, 1978
Gordon research conferences: winter program, 1979A M Cruickshank
Science (New York, N.Y.)|March 13, 1981
Gordon research conferencesA M Cruickshank
BMJ (Clinical Research Ed.)|October 14, 2011
Don't beta blockers still have a role in hypertension?John M Cruickshank
The American Journal of Cardiology|March 25, 1993
The xamoterol experience in the treatment of heart failureJ M Cruickshank
The New England Journal of Medicine|July 2, 1992
How far to lower blood pressureJ M Cruickshank
Cardiovascular Drugs and Therapy|August 1, 1993
Phosphodiesterase III inhibitors: long-term risks and short-term benefitsJ M Cruickshank
European Heart Journal|September 1, 1992
The role of coronary perfusion pressureJ M Cruickshank
Journal of Cardiovascular Pharmacology|January 1, 1995
The beta 1 hyperselectivity in beta-blocker treatmentJ M Cruickshank
Lancet (London, England)|June 28, 1980
Beta-blocking agentsJ M Cruickshank
Science (New York, N.Y.)|October 11, 1991
Gordon research conferencesA M Cruickshank
Pageof 35